Clinical Trials
- Kidney & Urinary Tract
Evaluating Biomarker-Guided Medication Changes in Kidney Transplant Patients
- Ages18 years - 70 years
- HIV/AIDS
Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study
- Ages18 years and older
- GenderBoth
- Myeloma
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation